EP3916080A4 - Porous cellular scaffold comprising serum-derived protein, and production method therefor - Google Patents

Porous cellular scaffold comprising serum-derived protein, and production method therefor Download PDF

Info

Publication number
EP3916080A4
EP3916080A4 EP20798792.6A EP20798792A EP3916080A4 EP 3916080 A4 EP3916080 A4 EP 3916080A4 EP 20798792 A EP20798792 A EP 20798792A EP 3916080 A4 EP3916080 A4 EP 3916080A4
Authority
EP
European Patent Office
Prior art keywords
serum
production method
method therefor
derived protein
porous cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20798792.6A
Other languages
German (de)
French (fr)
Other versions
EP3916080A1 (en
Inventor
Seung Yon Ju
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danagreen Co Ltd
Original Assignee
Danagreen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danagreen Co Ltd filed Critical Danagreen Co Ltd
Publication of EP3916080A1 publication Critical patent/EP3916080A1/en
Publication of EP3916080A4 publication Critical patent/EP3916080A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
    • C12N2537/10—Cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP20798792.6A 2019-04-29 2020-02-28 Porous cellular scaffold comprising serum-derived protein, and production method therefor Pending EP3916080A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190050051A KR102244760B1 (en) 2019-04-29 2019-04-29 Porous scaffold including inducible protein from serum and manufacturing method of the same
PCT/KR2020/002919 WO2020222414A1 (en) 2019-04-29 2020-02-28 Porous cellular scaffold comprising serum-derived protein, and production method therefor

Publications (2)

Publication Number Publication Date
EP3916080A1 EP3916080A1 (en) 2021-12-01
EP3916080A4 true EP3916080A4 (en) 2022-02-23

Family

ID=73028863

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20798792.6A Pending EP3916080A4 (en) 2019-04-29 2020-02-28 Porous cellular scaffold comprising serum-derived protein, and production method therefor

Country Status (6)

Country Link
US (1) US20220145243A1 (en)
EP (1) EP3916080A4 (en)
JP (1) JP7434358B2 (en)
KR (1) KR102244760B1 (en)
CN (1) CN113557294A (en)
WO (1) WO2020222414A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140213765A1 (en) * 2013-01-25 2014-07-31 I-Liang Lee Albumin tissue scaffold
EP2145635B1 (en) * 2007-03-29 2015-12-09 Centro Comunitario De Sangre Y Tejidos De Asturias Method for preparing three-dimensional structures for tissue engineering

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2917293B1 (en) * 2007-06-13 2010-11-26 Olivier Paul Christian Schussler MODIFIED COLLAGENIC CARRIAGE BY COVALENT GRAFTING OF MEMBRANE MOLECULES: METHODS AND APPLICATIONS FOR CONTRACTIVELY TISSUE ENGINEERING, CELL THERAPY AND CARDIOVASCULAR THERAPY
CA2878640C (en) * 2012-07-13 2023-10-24 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs
KR101877892B1 (en) * 2016-07-25 2018-07-12 주식회사 메디팹 Preparing method of cell culturing scaffold with double crosslinking
KR101924896B1 (en) * 2017-01-31 2018-12-04 한국세라믹기술원 Non-antibody protein scaffold based on fibronectin EDB and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2145635B1 (en) * 2007-03-29 2015-12-09 Centro Comunitario De Sangre Y Tejidos De Asturias Method for preparing three-dimensional structures for tissue engineering
US20140213765A1 (en) * 2013-01-25 2014-07-31 I-Liang Lee Albumin tissue scaffold

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LI PEI-SHAN ET AL: "A Novel Albumin-Based Tissue Scaffold for Autogenic Tissue Engineering Applications", SCIENTIFIC REPORTS, vol. 4, no. 1, 1 May 2015 (2015-05-01), XP055877232, DOI: 10.1038/srep05600 *
RUSLAN HAJI ET AL: "PROTEIN HYDROGELS AS TISSUE ENGINEERING SCAFFOLDS", THE UNIVERSITY OF MANCHESTER, 1 January 2015 (2015-01-01), pages 1 - 161, XP055876739, ISBN: 978-1-0739-1695-5, Retrieved from the Internet <URL:https://www.proquest.com/dissertations-theses/protein-hydrogels-as-tissue-engineering-scaffolds/docview/1780278154/se-2?accountid=29404 (accessed January 6, 2022).> [retrieved on 20220107] *
See also references of WO2020222414A1 *

Also Published As

Publication number Publication date
KR102244760B1 (en) 2021-04-27
WO2020222414A1 (en) 2020-11-05
JP7434358B2 (en) 2024-02-20
US20220145243A1 (en) 2022-05-12
CN113557294A (en) 2021-10-26
KR20200126478A (en) 2020-11-09
EP3916080A1 (en) 2021-12-01
JP2022527977A (en) 2022-06-07

Similar Documents

Publication Publication Date Title
EP3751638A4 (en) Solid electrolyte, and preparation method therefor and application thereof
EP3806551A4 (en) Energy-saving state transition method, terminal, and base station
EP3503515A4 (en) Mobile terminal, and method for operating same
EP3771248A4 (en) Method for determining transmission beam in wireless communication system supporting sidelink, and terminal therefor
EP4027627A4 (en) Mobile terminal and control method therefor
EP3873149A4 (en) Method by which terminal performs sidelink operation in wireless communication system, and terminal using method
EP3606169A4 (en) Cell selection and reselection method, and terminal
EP3806342A4 (en) Bluetooth communication method, and dual-mode bluetooth terminal
EP3573357A4 (en) Communication system, communication terminal, amf entity, and communication method
EP3531443A4 (en) Board-level architecture, preparation method therefor, and mobile terminal
EP4047845A4 (en) Operation method of ue associated with sci in wireless communication system
EP3952398A4 (en) Radio bearer configuration method, apparatus and system
EP3747477A4 (en) Bioink composition for cartilage regeneration, method for manufacturing customized scaffold for cartilage regeneration using same, and customized scaffold for cartilage regeneration manufactured using manufacturing method
EP3503514A4 (en) Mobile terminal, and method for controlling same
EP3960258A4 (en) Program, method and information terminal
EP3866384A4 (en) Method for sharing secure application in mobile terminal, and mobile terminal
EP3696986A4 (en) Self-tuning method, self-tuning system and mobile terminal
EP3621340A4 (en) D2d operation method by terminal in wireless communication system and terminal using said method
EP4060968A4 (en) Mobile terminal and control method therefor
EP3473331A4 (en) Porous membrane, and method for manufacturing porous membrane
EP3886506A4 (en) Cell selection or reselection method and apparatus, and terminal
EP3637829A4 (en) Method for determining establishment reason, and terminal
EP3952455A4 (en) Base station, communication system, communication method, and program
EP3986022A4 (en) Radio communication node and radio communication method
EP3769867A4 (en) Porous titanium-based sintered compact, method for manufacturing same, and electrode

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20220121

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/09 20100101ALI20220117BHEP

Ipc: C12N 5/077 20100101ALI20220117BHEP

Ipc: C12N 5/00 20060101AFI20220117BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231212